Brief: Enliven Therapeutics Announces Oral And Poster Presentations At The Society Of Hematologic Oncology (Soho) 2025 Annual Meeting
Aug 25 (Reuters) - Enliven Therapeutics Inc ELVN.O: ENLIVEN THERAPEUTICS ANNOUNCES ORAL AND POSTER PRESENTATIONS AT THE SOCIETY OF HEMATOLOGIC ONCOLOGY (SOHO) 2025 ANNUAL MEETING Source text: ID:nPnbJ3Jbwa Further company coverage: ELVN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses